XEINADIN NORTH LIMITED

Active Manchester

Accounting and auditing activities

51 employees website.com
Accounting and auditing activities
X

XEINADIN NORTH LIMITED

Accounting and auditing activities

Founded 8 Jun 2018 Active Manchester, United Kingdom 51 employees website.com
Accounting and auditing activities

Previous Company Names

PHILLIP CARROLL LIMITED 8 Jun 2018 — 12 Mar 2025
Accounts Submitted 4 Mar 2026 Next due 28 Feb 2026 4 months overdue
Confirmation Submitted 10 Jun 2025 Next due 21 Jun 2026 22 days remaining
Net assets £3M £1M 2025 year on year
Total assets £11M £9M 2025 year on year
Total Liabilities £9M £8M 2025 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

100 Barbirolli Square Manchester M2 3BD United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for XEINADIN NORTH LIMITED (11404925), an active company based in Manchester, United Kingdom. Incorporated 8 Jun 2018. Accounting and auditing activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jun → 31 May 2025
Type audit-exemption-subsidiary
Next accounts 31 May 2025
Due by 28 Feb 2026 4 months overdue

Balance Sheet & P&L (2019–2025)

Cash in Bank

£297.38k

Increased by £201.26k (+209%)

Net Assets

£2.55M

Increased by £1.35M (+112%)

Total Liabilities

£8.77M

Increased by £8.02M (+1075%)

Turnover

N/A

Employees

51

Increased by 25 (+96%)

Debt Ratio

77%

Increased by 39 (+103%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 May Year End
2024
31 May Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 409 Shares £409 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
1 Jun 2019105£105£1
1 Jun 201999£99£1
1 Jun 2019100£100£1
1 Jun 2019105£105£1

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (3)

Xeinadin Group Limited
51.2%
210
Xeinadin Group Limited
48.8%
200

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Xeinadin Group Limited

United Kingdom

Active
Notified 20 May 2022
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

David Philip Burgess

Ceased 20 May 2022

Ceased

Group Structure

Group Structure

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
1 Apr 2026OfficersTermination of David Philip Burgess as director on 1 Apr 2026
1 Apr 2026OfficersAppointment of Ms Samantha Jane Rainbow as director on 1 Apr 2026
4 Mar 2026OtherAudit exemption statement of guarantee by parent company for period ending 31/05/25
4 Mar 2026OtherNotice of agreement to exemption from audit of accounts for period ending 31/05/25
4 Mar 2026AccountsAnnual accounts made up to 31 May 2025
1 Apr 2026 Officers

Termination of David Philip Burgess as director on 1 Apr 2026

1 Apr 2026 Officers

Appointment of Ms Samantha Jane Rainbow as director on 1 Apr 2026

4 Mar 2026 Other

Audit exemption statement of guarantee by parent company for period ending 31/05/25

4 Mar 2026 Other

Notice of agreement to exemption from audit of accounts for period ending 31/05/25

4 Mar 2026 Accounts

Annual accounts made up to 31 May 2025

Recent Activity

Latest Activity

Termination of David Philip Burgess as director on 1 Apr 2026

1 months ago on 1 Apr 2026

Appointment of Ms Samantha Jane Rainbow as director on 1 Apr 2026

1 months ago on 1 Apr 2026

Audit exemption statement of guarantee by parent company for period ending 31/05/25

2 months ago on 4 Mar 2026

Notice of agreement to exemption from audit of accounts for period ending 31/05/25

2 months ago on 4 Mar 2026

Annual accounts made up to 31 May 2025

2 months ago on 4 Mar 2026